Jill Carroll
Director, Applied Genetic Technologies Corporation.
Companies
- Avalyn Pharma Inc.Board member Apr 29, 2026 to now1
- Arcellx, Inc.Board member Feb 3, 2022 to now2
- Applied Genetic Technologies CorporationBoard member Mar 26, 2014 to Apr 1, 20143
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Avalyn Pharma Inc. AVLN2,186,562 shares4$51.4M at $23.52May 1, 2026
- Arcellx, Inc.0 shares5Apr 28, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- May 1, 2026Bought 277,778 shares at $18.00 of Avalyn Pharma Inc.4
- May 1, 2026Converted 489,486 shares of Avalyn Pharma Inc.4
- May 1, 2026Converted 1,419,298 shares of Avalyn Pharma Inc.4
- Apr 28, 2026U 1,479,148 shares of Arcellx, Inc.5
- Mar 21, 2024Sold 504,263 shares at $70.55 of Arcellx, Inc.6
- Dec 14, 2023Sold 504,263 shares at $49.13 of Arcellx, Inc.7
- Jun 1, 2023Sold 25,556 shares at $44.35 of Arcellx, Inc.8
- May 31, 2023Sold 315,164 shares at $41.50 of Arcellx, Inc.8
- May 11, 2023Sold 6,485 shares at $46.15 of Arcellx, Inc.9
- May 11, 2023Sold 631,932 shares at $45.00 of Arcellx, Inc.9
- Feb 8, 2022Bought 1,600,000 shares at $15.00 of Arcellx, Inc.10
- Feb 8, 2022Converted 433,196 shares of Arcellx, Inc.10
- Feb 8, 2022Bought 66,667 shares at $15.00 of Arcellx, Inc.10
- Feb 8, 2022Converted 3,400,144 shares of Arcellx, Inc.10
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARAvalyn Pharma Inc., Board member
- 2SEC EDGARArcellx, Inc., Board member
- 3
- 4
- 5
- 6SEC EDGARForm 4 filed Mar 25, 2024
- 7SEC EDGARForm 4 filed Dec 18, 2023
- 8SEC EDGARForm 4 filed Jun 2, 2023
- 9SEC EDGARForm 4 filed May 15, 2023
- 10SEC EDGARForm 4 filed Feb 9, 2022